Straight From the Cutter's Mouth
    CME 0.5 General AMA PRA Category 1 Credits™

    Drs. Avni Finn, Priya Vakharia, and M. Ali Khan join for a journal club discussion of three recent articles from major ophthalmology journals:

    1. Persistent Opioid Use After Ophthalmic Surgery (https://www.aaojournal.org/article/S0161-6420(21)00315-8/abstract)

    2. Racial Disparities in Clinical Trials (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2778782)

    3. Telehealth During COVID-19 (https://www.ajo.com/article/S0002-9394(21)00213-0/fulltext)

    Relevant Financial Disclosures: Dr. Sridhar has consulted for Regeneron, Genentech, Alcon, Dorc, and Oxurion. Dr. Finn has consulted for Genentech and Allergan. Dr. Khan has consulted for Allergan, Dr. Vakharia has consulted for Genentech.

    CME Information

    Release: June 22, 2021; expires June 22, 2024

    Reviewers: Shriji Patel, MD

    Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

    Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

    Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

    Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.